期刊文献+

EMIT和FPIA测定丙戊酸、甲氨喋呤和环孢霉素A血药浓度的比较研究 被引量:7

Comparison of EMIT and FPIA Method in Determination of Valproic Acid,Methotrexate and Cyclosporine A Blood Concentration
原文传递
导出
摘要 目的比较均相酶放大免疫分析法(EMIT)和荧光偏振免疫分析法(FPIA)测定丙戊酸(VPA)、甲氨喋呤(MTX)和环孢霉素A(CsA)血药浓度结果,并评价两种测定方法所得结果的相关性。方法收集患者服药后的血样,采用EMIT和FPIA同时测定VPA、MTX和CsA血药浓度;以FPIA测定值为X,以EMIT测定值为Y,进行线性回归,评价其相关性。结果所得线性回归方程如下:YVPA=1.894 1+1.190 3X,r=0.983;YMTX=0.099 24+1.136X,r=0.992;YCsA=1.146 5+0.846 1X,r=0.971。EMIT测定血浆中VPA血药浓度较FPIA高11.2μg.mL 1,EMIT测定MTX血药浓度较FPIA高0.22μmol.L 1,EMIT测定CsA血药浓度较FPIA低20.6 ng.mL 1,差异有统计学意义(P<0.05)。结论 EMIT与FPIA测定VPA、MTX和CsA血药浓度差异具有统计学意义,在治疗药物监测中应予以注意。 OBJECTIVE To compare enzyme-multiplied immunoassay technique(EMIT) and fluorescence polarization immunoassay(FPIA) method in the determination of valproic acid(VPA), methotrexate(MTX) and cyclosporine A(CsA) concentrations in human plasma, and to evaluate the correlation of concentrations determined by EMIT and FPIA. METHODS Plasma samples were collected from patients. Both EMIT and FPIA method were employed to determine the concentrations of VPA, MTX and CsA. Regression analyses were performed (EMIT results as dependant, FPIA as independent variable) for the evaluation of correlation. RESULTS The regression equation of the results determined by FPIA (X) and EMIT (Y) were YVPA=--1.894 1+1.190 3X, r=0.983; YMTX=0.099 24+1.136X, r=0.992; Ycsg=-1.146 5+0.846 1X, r=0.971. VPA concentration determined by EMIT was 11.2 μg.mL^-1 higher than FPIA. MTX concentration determined by EMIT was 0.22 μmol.L^-1 higher than FPIA. CsA concentration determined by EMIT was 20.6 ng.mL^-1 lower than FPIA(P〈0.05). CONCLUSION Attentions should be paid to the differences ofVPA, MTX and CsA concentration determined by EMIT and FPIA methods in dosage modification.
出处 《中国现代应用药学》 CAS CSCD 2012年第8期740-744,共5页 Chinese Journal of Modern Applied Pharmacy
基金 南京市医学科技发展基金(YKK10052 YKK09077) 南京市科技发展计划(药学项目2011YX016)
关键词 酶放大免疫分析法 荧光偏振免疫分析法 丙戊酸 甲氨喋呤 环孢霉素A enzyme-multiplied immunoassay technique fluorescence polarization immunoassay valproic acid methotrexate cyclosporine A
  • 相关文献

参考文献2

二级参考文献18

  • 1张华年,陈渝军,刘智胜.毛细管气相色谱法测定癫痫患儿血清中丙戊酸浓度[J].中国医院药学杂志,2005,25(1):49-51. 被引量:16
  • 2李国豪,李萍,雷秀霞.丙戊酸血药浓度与血浆蛋白含量的相关性分析[J].中国药房,2005,16(20):1563-1564. 被引量:3
  • 3VINCENTI F, MENDEZ R, CURTIS J. A multicenter, prospective study of C2-monitored cyclosporine microemulsion in a U.S. population of de novo renal transplant recipients [J]. Transplantation, 2005, 80(7): 910-916.
  • 4JOHN U, ULLRICH S, ROSKOS M, et al. Two-hour postdose concentration: a reliable marker for cyclosporine exposure in adolescents with stable renal transplants [J]. Transplant Proc, 2005, 37(3): 1608-1611.
  • 5CITTERIO F, SCATS, MC, ROMAGNOLI J, et al. Results of a three-year prospective study of C2 monitoring in long-term renal transplant recipients receiving cyclosporine microemulsion [J]. Transplantation, 2005, 79(7): 802-806.
  • 6FERRARESSO M, CITTERIO F, GHIO L, et al. C2 is an age-independent parameter for optimal cyclosporine exposure in long-term kidney transplant recipients [J]. Transplant Proc, 2004, 36(9): 2656-2658.
  • 7DI PAOLO S, TEUTONICO A, INFANTE B, et al. Experience with cyclosporine: approaching the therapeutic window for C2 levels in maintenance kidney transplant recipients [J]. Transplant Proc, 2004, 36(2): 434-436.
  • 8MARCEN R, VILLAFRUELA J J, PASCUAL J. Clinical outcomes and C2 cyclosporin monitoring in maintenance renal transplant recipients: 1 year follow-up study [J]. Nephrol Dial Transplant, 2005, 20(4): 803-810.
  • 9LEMAHIEU WP, MAES BD, VERBEKE K, et al. Alteration of CYP3A4 and P-glycoprotein in vivo with time in renal graft recipients [J]. Kidney Int, 2004, 66(2): 433-440.
  • 10CHEN X Q, JIN Y Y, TANG G. New Materia Medica(新编药物学)[M].16th ed. Beijing: People's Medical Publishing House, 2007: 223.

共引文献13

同被引文献56

  • 1顾龙君.儿童急性淋巴细胞白血病诊疗建议(第三次修订草案)[J].中华儿科杂志,2006,44(5):392-395. 被引量:476
  • 2王彬,娄子洋,柴逸峰,张国庆.HPLC-MS法和mFPIA法测定全血环孢霉素A及其代谢物的比较[J].药物分析杂志,2007,27(9):1378-1381. 被引量:4
  • 3Fotoohi K,Skarby T,Soderhall S,et al.Interference of 7-hydroxy-methotrexate with the determination of methotrexate in plasma sam-ples from children with acute lymphoblastic leukemia employingroutine clinical assays[J].J Chromatogr B Analyt Technol BiomedLife Sci,2005,817(2):139-144.
  • 4Alnaim L.Therapeutic drug monitoring of cancer chemotherapy[J].J Oncol Pharm Pract,2007,13(4):207-221.
  • 5中国医院协会药事管理专业委员会,卫生部医院管理研究所药事管理研究部.新增临床药师培训专业指南,新增专业临床药师培训登记手册[Z].2011:1-16.
  • 6Slordal L, Prytz PS, Pettersen I, et al. ents in plasma: comparison of enzyme technique, TDx fluorescence polarization Methotrexate measurem- Y, pressure liquid chromatography [ J ]. Ther Drug Monit, (3) : 368-372.
  • 7Y and high 1986, 8 Liappis N. Determining the methotrexate concentration in serum with the fluorescence polarization Ly (FPIA)-a comparison with the enzyme immunoassay ( EMIT ) [ J ]. Klin Padiatr, 1986, 198(1) : 33-36.
  • 8Klapkova E, Kukacka J, Kotaska K, et al. The influence of 7- OH methotrexate metabolite on clinical relevance of methotrexate determination [J]. Clin Lab, 2011, 57(7-8) : 599-606.
  • 9Fotoohi K, Skarby T, Soderhall S, et al. Interference of 7- hydroxymethotrexate with the determination of methotrexate inplasma samples from children with acute lymphoblastic leukemia employing routine clinical assays [ J ]. J Chromatogr B Analyt Technol Biomed Life Sci, 2005, 817 (2) : 139-144.
  • 10Albertioni F, Rask C, Eksborg S, et al. Evaluation of elinical assays for measuring high-dose methotrexate in plasma [ J ]. Clin Chem, 1996, 42(1) : 39-44.

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部